Michael Patterson

Michael Patterson has a diverse work experience spanning multiple pharmaceutical companies. Michael is currently serving as the Chief Executive Officer - North America at Curium Pharma since January 2022. Prior to this, they held the role of Vice President, Marketing - North America at Curium Pharma from October 2017 to December 2021.

Before joining Curium Pharma, Michael worked at Mallinckrodt Pharmaceuticals from 2012. During their tenure, they served as the Sr. Director Patient Services and Reimbursement, where they successfully improved customer service and business performance through the implementation of new strategies. Michael also worked as the Special Assistant to the President - Commercial North America, contributing to a successful multi-billion acquisition and enhancing the capabilities of the Commercial organization through the deployment of new execution models and data platforms.

Michael has also had experience at Covidien as a Marketing Senior Product Manager - Specialty Pharmaceuticals, where they drove revenue growth and conducted a successful product life cycle for Exalgo.

Their earlier experiences include working at sanofi-aventis, where they held various roles such as District Sales Manager, Multaq Marketing, and Manager, Initial Training. Michael achieved significant sales growth and improvement in sales representatives' business acumen and product knowledge during their tenure.

Throughout their career, Michael Patterson has demonstrated strong leadership skills and a track record of success in driving business growth and implementing strategic initiatives.

Michael Patterson obtained their Bachelor of Science degree from the University of Illinois Urbana-Champaign in 1997. Michael later pursued a Master of Business Administration (M.B.A.) at Washington University in St. Louis from 2015 to 2016.